检索结果 - Anne M. Cropp

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases 由 Rachel A. Freedman, Rebecca Gelman, Carey K. Anders, Michelle Melisko, Heather A. Parsons, Anne M. Cropp, Kelly M. Silvestri, Christine M. Cotter, Kathryn P. Componeschi, Juan M. Marte, Roisín M. Connolly, Beverly Moy, Catherine Van Poznak, Kimberly Blackwell, Shannon L. Puhalla, Rachel C. Jankowitz, Karen L. Smith, Nuhad K. Ibrahim, Timothy J. Moynihan, Ciara C. O’Sullivan, Julie R. Nangia, Polly Niravath, Nadine Tung, Paula R. Pohlmann, Robyn Burns, Mothaffar F. Rimawi, Ian E. Krop, Antonio C. Wolff, Eric P. Winer, Nancy U. Lin